Contact Us
Center for Infectious Disease and Immunity
Tularemia Vaccine Development Contract MSC 11 6020
1 University of New Mexico
Albuquerque, NM 87131-0001

email
Phone: (505) 272-5872
Fax: (505) 272-9912

Tularemia Vaccine Development Contract

Articles & Other Info on TVDC

Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant induces protective immunity against homotypic and heterotypic challenge
By Yu Conga, Jieh-Juen Yua, M. Neal Guentzela, Michael T. Bertonb, Janakiram Seshua, Karl E. Klosea, Bernard P. Arulanandama
Vaccine, 27 (41), p.5554-5561, Sep 2009
...cells were infected with KKF235 or its parental...strain (U112), using a MOI of 10. The number...challenged i.n. with 104, 105, 106or...organs after i.n. vaccination. BALB/c mice were challenged with 106CFU of KKF235 and...c mice received a single immunizing...

University leads microscopic battle vs. bioweapons
By Sue Vorenberg, Scripps Howard News Service, November 20, 2005

Tularemia Vaccine Contracts Among New NIAID Biodefense Awards
NIH Press Release, October 3, 2005

Construction of targeted insertion mutations in Francisella tularensis subsp. novcida
Jirong Liu, Xhavit Zogaj, Jeffrey R. Barker, and Karl E. Klose
University of Texas San Antonio, San Antonio, TX, USA

Oral live vaccine strain induced protective immunity